Something changed in antibody discovery that the field spent a decade waiting for. Antibodies designed on a computer, rather than fished from an immunized animal or a display library, are now being validated in the lab at binding rates and affinities that hold their own against molecules found the traditional way. What was a promising…
Shots:
Chai Discovery has entered a collaboration with BMS to advance the discovery of therapeutic antibodies using artificial intelligence
As per the deal, BMS will leveraging Chai’s AI models and platform capabilities including its molecular folding & design models to support the discovery of antibody candidates across its portfolio and to support the development of…
Shots:
Biocytogen has partnered with Sihuan Pharmaceutical to discover innovative therapies across multiple areas, incl. weight loss
As per the deal, Biocytogen and Sihuan will combine Biocytogen’s fully human antibody discovery platform with Sihuan’s development, manufacturing, & commercialization capabilities
In this collaboration, Biocytogen will leverage its integrated platforms, incl. target-humanized mouse models, in vivo efficacy…
Shots:
Infinimmune has partnered with Merck to discover & develop antibody candidates against multiple undisclosed targets selected by Merck using Infinimmune’s human-first antibody discovery platform
As per the deal, Infinimmune will use its Anthrobody discovery platform & Glimpse antibody language model to discover & optimize antibodies from human immune repertoires, enabling large-scale B-cell screening to…

